advertisement

Topcon

11.13.4 Betablocker and prostaglandin (7)

Showing records 1 to 7

Display all abstracts in classification 11.13.4 Betablocker and prostaglandin

Search within classification 11.13.4 Betablocker and prostaglandin
25535 A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Facio A C; Reis A S; Vidal K S; de Moraes C G; Suzuki R; Hatanaka M; Susanna R
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 447-451
25059 Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma
Konstas AG; Holló G; Mikropoulos D; Tsironi S; Haidich AB; Embeslidis T; Georgiadou I; Irkec M; Melamed S
British Journal of Ophthalmology 2010; 94: 209-213
25463 Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
Teus M A; Miglior S; Laganovska G; Volksone L; Romanowska-Dixon B; Gos R; Hollo G
Clinical Ophthalmology 2009; 3: 629-636
25063 Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus lantanoprost or timolol monotherapy
Varma R Md Mph; Hwang LJ Phd; Grunden JW Pharmd; Bean GW Bs
British Journal of Ophthalmology 2010; 94: 80-84
25067 Fixed Combination of Latanoprost and Timolol vs Individual Components for Primary Open-Angle Glaucoma or Ocular Hypertension: A Randomized, Double-Masked Study
Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler
Archives of Ophthalmology 2010; 128: 165-172
25446 Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
Ozkurt Y B; Sengor T; Evciman T; Haboglu M; Bas G; Aydin S
Clinical Ophthalmology 2009; 3: 337-339
25455 Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
Bergstrom A; Maurel F; Le Pen C; Lamure E; Kent M; Bardoulat I; Berdeaux G
Clinical Ophthalmology 2009; 3: 471-481

Issue 12-1

Change Issue


advertisement

Oculus